Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about JNJ
Recent news which mentions JNJ
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Cancer Drugs Propel J&J Beyond Wall Street Estimates
October 15, 2024
Tickers
JNJ
WBA
Tags
contributors
Biotech
WBA
From
Benzinga
Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript
October 15, 2024
Tickers
JNJ
Tags
Market News
Recent Press Releases
JNJ
From
Motley Fool
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
October 15, 2024
Tickers
CDNA
ERIC
JNJ
MGTX
Tags
JNJ
WOLF
Trading Ideas
From
Benzinga
Chipmaker Stocks Sink On ASML Earnings Leak, Oil Eyes Worst 1-Day Drop This Year, Small Caps Rally: What's Driving Markets Tuesday?
October 15, 2024
Tickers
AAL
ARM
ASML
BAC
Tags
SOXX
SCHW
midday report
From
Benzinga
Google Goes Nuclear For AI Power, Israeli Restraint Impacts Stocks, Gold, And Oil
October 15, 2024
Tickers
AAPL
AMZN
BAC
CEG
Tags
UNH
AAPL
QQQ
From
Benzinga
Johnson & Johnson's Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition
October 15, 2024
Tickers
JNJ
NEWS
Tags
Top Stories
Earnings
JNJ
From
Benzinga
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
October 15, 2024
Tickers
AMD
BA
BAC
C
Tags
GS
Benzinga
Mary Daly
From
Benzinga
Jim Cramer Says Earnings Season Will Fuel Market's Record Run, But Warns Of This 'Horrendous' Headwind That Could Apply Brakes To Rally
October 15, 2024
Tickers
BAC
C
GS
JBHT
Tags
PNC
Top Stories
SPY
From
Benzinga
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
October 14, 2024
Tickers
JNJ
NEWS
Tags
Most Accurate Analysts
News
Earnings
From
Benzinga
This Is What Whales Are Betting On Johnson & Johnson
October 14, 2024
Tickers
JNJ
Tags
Market News
Markets
JNJ
From
Benzinga
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
October 14, 2024
Tickers
JNJ
LLY
NEWS
Tags
LLY
JNJ
Health Care
From
Benzinga
Johnson & Johnson Preps For Q3 Earnings As MedTech Expands, But Stock Sends Mixed Signals
October 14, 2024
Tickers
JNJ
NEWS
Tags
Expert Ideas
Technicals
Stories That Matter
From
Benzinga
Columbus Day: Is Stock Market Open Today?
October 14, 2024
Tickers
ABT
BAC
JNJ
NEWS
Tags
TSM
NASDAQ
News
From
Benzinga
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
October 13, 2024
Tickers
AMZN
CHD
CLX
JNJ
Tags
PG
WMT
KVUE
From
Motley Fool
Market Whales and Their Recent Bets on JNJ Options
October 11, 2024
Tickers
JNJ
Tags
Benzinga
Options
JNJ
From
Benzinga
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
October 11, 2024
Tickers
BX
GS
GSK
HLN
Tags
GS
Biotech
MS
From
Benzinga
What Analysts Are Saying About Johnson & Johnson Stock
October 10, 2024
Tickers
JNJ
Tags
Analyst Ratings
BZI/AAR
Benzinga
From
Benzinga
Insights Into Johnson & Johnson's Performance Versus Peers In Pharmaceuticals Sector
October 10, 2024
Tickers
JNJ
NEWS
Tags
News
BZI/IA
Trading Ideas
From
Benzinga
1 Vanguard Index Fund Could Turn $500 Per Month Into a $968,400 Portfolio That Pays $16,000 in Annual Dividend Income
October 09, 2024
Tickers
AAPL
AVGO
JNJ
JPM
Tags
JPM
MA
VIG
From
Motley Fool
What To Expect When Johnson & Johnson Reports Q3 Earnings Next Week?
October 08, 2024
Tickers
JNJ
NEWS
Tags
General
Briefs
Price Target
From
Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
October 04, 2024
Tickers
JNJ
NEWS
TAK
Tags
General
Briefs
Stories That Matter
From
Benzinga
2 Smart Income Stocks to Buy Right Now
October 04, 2024
Tickers
JNJ
KO
Tags
JNJ
Recent Press Releases
Market News
From
Motley Fool
Johnson & Johnson's Options: A Look at What the Big Money is Thinking
October 02, 2024
Tickers
JNJ
Tags
Market News
Markets
BZI/UOA
From
Benzinga
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
October 02, 2024
Tickers
JNJ
NEWS
PFE
Tags
Equities
Large Cap
News
From
Benzinga
Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients
September 30, 2024
Tickers
JNJ
LEGN
NEWS
Tags
LEGN
General
Biotech
From
Benzinga
2 Excellent Dividend Stocks to Buy With Less Than $200
September 28, 2024
Tickers
ABT
JNJ
Tags
Market News
Recent Press Releases
JNJ
From
Motley Fool
Johnson & Johnson Reports Updated Data From Two Early-Stage Multiple Myeloma Studies Of Talvey Combo Treatment
September 27, 2024
Tickers
JNJ
NEWS
Tags
JNJ
Health Care
Top Stories
From
Benzinga
In-Depth Analysis: Johnson & Johnson Versus Competitors In Pharmaceuticals Industry
September 26, 2024
Tickers
JNJ
NEWS
Tags
Market News
Markets
News
From
Benzinga
Why Masimo Stock Crushed the Market Today
September 25, 2024
Tickers
JNJ
KFY
MASI
Tags
Market News
Recent Press Releases
KFY
From
Motley Fool
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
Tickers
GS
GSK
HLN
JNJ
Tags
SNY
News
Large Cap
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.